Physician profile

Michael Ombrellino

Vascular Surgery · Morristown, NJ

NPI 1114997426

$11,898.70

in general payments reported to CMS, 2019-2025

29 companies · $1,480 in 2025

The $1,480 reported for 2025 was more than what a typical Vascular Surgery provider received nationally (typical 2025 total: $927).

See the full distribution for Vascular Surgery

Payments by year

General payments by program year, as reported to CMS.

What the payments were for

Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.

View as a table
Payment typeAmount (2023-2025)
Food and Beverage$6,168.47
Travel and Lodging$1,293.96

Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.

Who reported paying

General payments only, as reported to CMS. Product names cover 2023-2025.

CompanyGeneral paymentsYearsTop products
Penumbra, INC. $3,732.97 2019-2025 Indigo System, Ruby Coil, Penumbra System
W. L. Gore & Associates, INC. $1,393.59 2021-2025 Gore Viabahn Vbx Balloon Expandable Endo, Excluder Conformable Aaa Endoprosthesis With Active Control, Gore Tag Thoracic Branch Endoprosthesis
Inari Medical, INC. $1,138.64 2019-2024 Ct Thrombectomy System Kit, Flowtriever Catheter, S
Medtronic, INC. $1,125.95 2021-2025 Hawkone, Endurant Iis, Heli-Fx Endoanchor System
Silk Road Medical, INC. $649.15 2019-2024 Enroute Transcarotid Neuroprotection System, Enroute Transcarotid Stent, Enroute Enflate Transcarotid Rx Balloon Dilatation Catheter
Bolton Medical INC $517.90 2022-2025 Treo Abdominal Stent-Graft System, Relay Thoracic Stent-Graft With Plus Delivery System
Convatec INC. $435.91 2024
Cardiovascular Systems INC. $431.64 2019-2022
Bard Peripheral Vascular, INC. $393.97 2020-2024 Venclose Maven Catheter
Endologix LLC $378.27 2020-2022
Acera Surgical, INC. $257.53 2023-2025 Restrata Wound Matrix
Angiodynamics, INC. $207.64 2023-2024 Auryon Laser System 100-120 Vac, Venacure 1470 Pro
Tactile Systems Technology INC $182.34 2023-2024 Flexitouch Plus, Entre Plus
Sanara Medtech INC. $150.00 2025 Celleraterx
Shockwave Medical, INC $125.00 2023 Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter
Show all 29 companies
CompanyGeneral paymentsYearsTop products
Ekos Corporation $106.74 2019
Medtronic Vascular, INC. $102.94 2019
Lemaitre Vascular, INC. $96.85 2022-2025 Restoreflow, Pruitt F3 Carotid Shunt
Smith+Nephew, INC. $87.23 2021-2025 Collagenase Santyl
Kci USA, INC. $83.55 2019
Cvrx, INC. $74.62 2023 Barostim Neo System
Cook Medical LLC $49.10 2021
Janssen Pharmaceuticals, INC $44.71 2019-2021
Terumo Medical Corporation $35.34 2022
Biocompatibles, INC. $24.32 2019
Boston Scientific Corporation $23.62 2025 Enroute Transcarotid Neuroprotection System
Stryker Corporation $20.94 2025 Flowtriever
E.R. Squibb & Sons, L.L.C. $15.52 2025 Eliquis
Pfizer INC. $12.72 2023

Drugs and devices associated with these payments

CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.

If you want to bring it up

Most clinicians are glad to talk about this. A respectful way in:

These are normal questions. A good clinician will welcome them.

Share this page

Payment summary

Michael Ombrellino

$11,898.70

in general payments reported 2019-2025

Years
2019-2025
Top company
Penumbra, INC.
Context
The $1,480 reported for 2025 was more than what a typical Vascular Surgery provider received nationally (typical 2025 total: $927).

https://glasscript.com/doctor/141257/michael-ombrellino

Source: CMS Open Payments, program years 2019-2025. Payments are legal and often routine.

Download CSV

The CSV has this whole record: totals, yearly figures, every listed company, payment types, and product associations.

Keep an eye on this page

Get an email when the next June refresh changes this page. No account needed.

Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.